menu
    • menu

    Company profile for NeuBase Therapeutics

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NeuBase Therapeutics, Inc., is accelerating the genetic revolution developing a new class of designer synthetic medicines.NeuBase's targeted PATrOL™ therapies are centered around its proprietary drug scaffold to address genetic diseases at the DNA or RNA level by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules. With an initial focus on ...
    NeuBase Therapeutics, Inc., is accelerating the genetic revolution developing a new class of designer synthetic medicines.NeuBase's targeted PATrOL™ therapies are centered around its proprietary drug scaffold to address genetic diseases at the DNA or RNA level by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules. With an initial focus on silencing disease-causing mutations in debilitating neurological, neuromuscular, and oncologic disorders, NeuBase is committed to redefining medicine for the millions of patients with both common and rare conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuBase TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Technology Drive Pittsburgh, PA 15219
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neubasetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neubase-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/neubaseinc?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
    NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

    05 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/05/2858735/0/en/NeuBase-Therapeutics-Announces-Receipt-of-Notice-from-Nasdaq.html

    GLOBENEWSWIRE
    05 Apr 2024
    Share Share
    NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder
    NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder

    08 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/08/2739989/0/en/NeuBase-Therapeutics-Issues-Statement-Regarding-Filing-By-Shareholder.html

    GLOBENEWSWIRE
    08 Sep 2023
    Share Share
    NeuBase Therapeutics to Explore Strategic Alternatives
    NeuBase Therapeutics to Explore Strategic Alternatives

    03 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/03/2717810/0/en/NeuBase-Therapeutics-to-Explore-Strategic-Alternatives.html

    GLOBENEWSWIRE
    03 Aug 2023
    Share Share
    NeuBase Announces Closing of $5 Million Concurrent Registered Direct Offerin
    NeuBase Announces Closing of $5 Million Concurrent Registered Direct Offerin

    30 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/30/2698075/0/en/NeuBase-Announces-Closing-of-5-Million-Concurrent-Registered-Direct-Offering-and-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    30 Jun 2023
    Share Share
    NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors
    NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors

    29 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/29/2696990/0/en/NeuBase-Presents-Non-Human-Primate-Data-Illustrating-Stealth-Editors-are-Non-Immunogenic-Opening-the-Door-to-Redosing.html

    GLOBENEWSWIRE
    29 Jun 2023
    Share Share
    NeuBase Announces $5 Million Concurrent Registered Direct Offering
    NeuBase Announces $5 Million Concurrent Registered Direct Offering

    28 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/28/2696563/0/en/NeuBase-Announces-5-Million-Concurrent-Registered-Direct-Offering-and-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    28 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search